Table 2. Association between circZNF609 expression levels and clinical parameters in CAD patients.
| Clinical characteristics | circZNF609 expression | ||||
|---|---|---|---|---|---|
| Spearman correlation | Multiple linear regression | ||||
| r | P | β | P | ||
| Sex | −0.012 | 0.833 | – | – | |
| Age | −0.094 | 0.089 | – | – | |
| BMI | 0.107 | 0.068 | – | – | |
| Smoking | 0.076 | 0.166 | – | – | |
| Alcoholism | −0.018 | 0.750 | – | – | |
| Hypertension | −0.023 | 0.678 | – | – | |
| Hyperlipidemia | 0.136 | 0.013* | – | – | |
| T2DM | −0.048 | 0.386 | – | – | |
| WBC | −0.092 | 0.104 | – | – | |
| NEU | −0.142 | 0.012* | – | – | |
| LYM | 0.237 | <0.0001* | 0.16 | 0.01* | |
| MON | −0.02 | 0.727 | – | – | |
| PLT | 0.001 | 0.987 | – | – | |
| CRP | −0.137 | 0.025* | −0.138 | 0.026* | |
| NT-proBNP | −0.050 | 0.402 | – | – | |
| cTnT | 0.051 | 0.378 | – | – | |
| Gensini scores | −0.153 | 0.006* | – | – | |
*, P<0.05. CAD, coronary artery disease; BMI, body mass index; T2DM, type 2 diabetes mellitus; WBC, white blood cell counts; NEU, neutrophil counts; LYM, lymphocyte counts; MON, monocyte counts; PLT, platelet counts; CRP, c-reaction protein; NT-proBNP, N-terminal pro-brain natriuretic peptide; cTnT, cardiac troponin T.